4:54 PM
Feb 07, 2011
 |  BC Extra  |  Clinical News

EpiCept gains on EpiCept-NP1 data

EpiCept Corp. (NASDAQ:EPCT; SSE:EPCT) gained $0.10 (13%) to $0.85 on Monday after the company said EpiCept NP-1 met the primary endpoint in a...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >